Free Trial

Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by CIBC Private Wealth Group LLC

Axon Enterprise logo with Aerospace background
Remove Ads

CIBC Private Wealth Group LLC lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 1.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 92,539 shares of the biotechnology company's stock after selling 1,351 shares during the period. CIBC Private Wealth Group LLC owned approximately 0.12% of Axon Enterprise worth $53,426,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Public Sector Pension Investment Board lifted its holdings in shares of Axon Enterprise by 19.2% in the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company's stock valued at $1,240,000 after buying an additional 500 shares during the period. Friedenthal Financial lifted its holdings in Axon Enterprise by 961.7% in the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company's stock valued at $808,000 after acquiring an additional 1,231 shares during the period. Principal Financial Group Inc. boosted its position in Axon Enterprise by 33.1% in the 3rd quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company's stock worth $54,466,000 after purchasing an additional 33,869 shares in the last quarter. XTX Topco Ltd grew its stake in shares of Axon Enterprise by 20.6% during the 3rd quarter. XTX Topco Ltd now owns 5,650 shares of the biotechnology company's stock worth $2,258,000 after purchasing an additional 964 shares during the period. Finally, Artemis Investment Management LLP increased its holdings in shares of Axon Enterprise by 21.4% during the 4th quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company's stock valued at $56,528,000 after purchasing an additional 16,792 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Axon Enterprise Trading Down 5.9 %

Shares of AXON traded down $31.69 during midday trading on Friday, reaching $508.00. The company had a trading volume of 310,107 shares, compared to its average volume of 801,576. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a 50 day simple moving average of $584.52 and a 200-day simple moving average of $552.70. The stock has a market cap of $38.92 billion, a PE ratio of 131.27, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13.

Analyst Ratings Changes

Several analysts recently commented on the stock. Barclays restated a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Robert W. Baird increased their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research report on Friday, December 6th. Northcoast Research lowered Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $600.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 26th. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $604.67.

Read Our Latest Research Report on AXON

Insider Transactions at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 6.10% of the company's stock.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Read More

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads